Similarly, in CDK4-addicted HR + /HER2- breast cancer models (MCF7 and CAMA1), the impact on cell cycle proteins following CDK4 depletion was more pronounced than CDK2 depletion (Fig. 1E). This evidence concerns the gene ERBB2 and breast cancer.